Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL541928 | 0.93 | TSHR (0.43) | TSHRTHRB | |
| SCHEMBL2041337 | 0.91 | TSHR (0.39) | TSHRTHRB | |
| SCHEMBL541535 | 0.90 | THRB (0.38) | TSHRTHRB | |
| SCHEMBL28637235 | 0.90 | TSHR (0.40) | TSHRTHRB | |
| SCHEMBL6851650 | 0.85 | TSHR (0.38) | TSHRTHRB | |
| SCHEMBL2037326 | 0.84 | TSHR (0.43) | TSHRTHRB | |
| SCHEMBL28874078 | 0.84 | TSHR (0.41) | TSHRTHRB | |
| SCHEMBL2037549 | 0.83 | TSHR (0.44) | TSHRTHRB | |
| SCHEMBL2036641 | 0.81 | THRB (0.39) | TSHRTHRB | |
| SCHEMBL28874076 | 0.81 | TSHR (0.41) | TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240189121-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2024-06-13 | — | — | US | claimed |
| US-11903850-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2024-02-20 | — | — | US | claimed |
| US-20230036800-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2023-02-02 | — | — | US | claimed |
| US-20220227954-A1 | POLYMERIC SURFACE HAVING REDUCED BIOMOLECULE ADHESION TO THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | OAKTREE FUND ADMINISTRATION, LLC | 2022-07-21 | — | — | US | claimed |
| US-11369497-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2022-06-28 | — | — | US | claimed |
| EP-3862384-A2 | POLYMERIC SUBSTRATE WITH A SURFACE HAVING REDUCED BIOMOLECULE ADHESION, AND THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | SiO2 Medical Products, Inc. (US) | 2021-08-11 | — | — | EP | claimed |
| US-20210068991-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2021-03-11 | — | — | US | claimed |
| US-20190125555-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2019-05-02 | — | — | US | claimed |
| EP-2875833-B1 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2018-08-08 | — | — | EP | claimed |
| US-9668890-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2017-06-06 | — | — | US | claimed |
| WO-2015077081-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP (US) | 2015-05-28 | — | — | WO | claimed |
| US-20150148882-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2015-05-28 | — | — | US | claimed |
| EP-2875833-A1 | Anti-thrombogenic medical devices and methods | Covidien LP (US) | 2015-05-27 | — | — | EP | claimed |
| US-20150140344-A1 | COATED MEDICAL DEVICES | COVIDIEN LP | 2015-05-21 | — | — | US | claimed |
| US-20100094339-A1 | COATING COMPOSITIONS | COVIDIEN LP | 2010-04-15 | — | — | US | claimed |
| EP-2120824-A1 | COATING COMPOSITIONS | Tyco Healthcare Group LP (US) | 2009-11-25 | — | — | EP | claimed |
| WO-2008143654-A1 | COATING COMPOSITIONS | TYCO HEALTHCARE GROUP LP (US) | 2008-11-27 | — | — | WO | claimed |
| WO-2024127135-A2 | METHODS FOR SILANIZATION OF SUBSTRATES | MEDTRONIC, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| US-6214957-B1 | POLYMER CONTAINING HYDROPHILIC MONOMERS HAVING AMMONIO ETHYL PHOSPHATE SIDE CHAINS, POLYMER IS SOLUBLE IN SOLVENT CONTAINING WATER | NOF CORPORATION (JP) | 2001-04-10 | — | — | US | disclosed |
| EP-0947244-A1 | SOLUBILIZERS, EMULSIFIERS AND DISPERSANTS | NOF CORPORATION (JP) | 1999-10-06 | — | — | EP | disclosed |